ong-term follow-up study of patients who have previouslybeen exposed to UCART19
Not Applicable
Recruiting
- Conditions
- advanced lymphoid malignancies
- Registration Number
- JPRN-jRCT2013190001
- Lead Sponsor
- clinical operation department International center for therapeutic research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
All patients dosed with UCART19 must be enrolled in the long-term follow up study after the completion of the parent study.
Exclusion Criteria
No exclusion criteria for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method